Screening usually refers to population-based screening ofasymptomatic people, the purpose of which is to find the cancerprecursors (= prevention) or early-stage cancers (= early detection).
At best, screening can help find those asymptomatic people who arein cancer risk groups.
GastroPanel is suitable for this, because early detection of atrophicgastritis is the best prevention for cancer. When GastroPanel isapplied to the risk screening of gastric cancer, concrete cost savingscan be achieved:
- Fewer surgical and oncological treatments
- Reduce labour loss due to premature death
- First-line diagnosis of dyspeptic patients
- Less sick leave (caused by dyspepsia, ulcer etc.)
The developed screening model calculation can estimate how muchsavings are generated when the GastroPanel test is used instead oftraditional gastroscopy. In this case, at best, 80% of gastroscopiescan be shown to be unnecessary when the GastroPanel result isperfectly normal.